These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32998307)
1. Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). Ben Abderrazek R; Chammam S; Ksouri A; Perilli M; Dhaouadi S; Mdini I; Benlasfar Z; Amicosante G; Bouhaouala-Zahar B; Piccirilli A Molecules; 2020 Sep; 25(19):. PubMed ID: 32998307 [TBL] [Abstract][Full Text] [Related]
2. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria. Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785 [TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013 [TBL] [Abstract][Full Text] [Related]
4. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem. Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874 [TBL] [Abstract][Full Text] [Related]
5. A close look onto structural models and primary ligands of metallo-β-lactamases. Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711 [TBL] [Abstract][Full Text] [Related]
6. Characterization of purified New Delhi metallo-β-lactamase-1. Thomas PW; Zheng M; Wu S; Guo H; Liu D; Xu D; Fast W Biochemistry; 2011 Nov; 50(46):10102-13. PubMed ID: 22029287 [TBL] [Abstract][Full Text] [Related]
8. A Kinetic Study of the Replacement by Site Saturation Mutagenesis of Residue 119 in NDM-1 Metallo-β-Lactamase. Marcoccia F; Mercuri PS; Galleni M; Celenza G; Amicosante G; Perilli M Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784851 [TBL] [Abstract][Full Text] [Related]
9. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases. Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166 [TBL] [Abstract][Full Text] [Related]
10. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach. Muteeb G; Alsultan A; Farhan M; Aatif M Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073 [TBL] [Abstract][Full Text] [Related]
11. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases. Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568 [TBL] [Abstract][Full Text] [Related]
12. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases. Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091 [TBL] [Abstract][Full Text] [Related]
13. Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1). Zhai L; Jiang Y; Shi Y; Lv M; Pu YL; Cheng HL; Zhu JY; Yang KW Bioorg Chem; 2022 Sep; 126():105910. PubMed ID: 35653899 [TBL] [Abstract][Full Text] [Related]